Skip to main content
Premium Trial:

Request an Annual Quote

Strand Diagnostics to Receive $30M Investment from Nantworks

NEW YORK (GenomeWeb News) – Strand Diagnostics today said it will receive an investment of $30 million from Nantworks to further grow the firm, scale its operational infrastructure, and expand sales and marketing efforts.

The funding will be provided over three years.

Strand has developed its know error system, which uses bar coding, forensic chain-of-custody principles, and DNA testing "to complete the diagnostic testing cycle before initiating treatment." The Indianapolis firm calls this process DNA Specimen Provenance Assignment, or DSPA, and said that the know error system ensures that a surgical biopsy sample being assessed belongs exclusively to the patient being diagnosed.

"DSPA testing completes the cancer diagnostic testing cycle to provide patients a complete and accurate diagnosis, allowing physicians to proceed with the best treatment for the appropriate patient," the company's co-founder Peter Knapp said in a statement.

The know error system was launched in 2009 and the most popular know error offerings are for breast biopsy and prostate biopsy, the company said.

Nantworks, based in Los Angeles, said that it is building "an integrated evidence-based, genomically informed, personalized approach to the delivery of care and the development of next-generation diagnostics and therapeutics."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.